{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:34:22Z","timestamp":1781001262825,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.comppsych.2022.152305","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T21:07:09Z","timestamp":1647378429000},"page":"152305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Optimizing first line treatments for adults with OCD"],"prefix":"10.1016","volume":"115","author":[{"given":"V.","family":"Nezgovorova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Fineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.comppsych.2022.152305_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/YIC.0000000000000314","article-title":"Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders","volume":"35","author":"Fineberg","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.comppsych.2022.152305_bb0010","author":"NICE"},{"key":"10.1016\/j.comppsych.2022.152305_bb0015","author":"APA"},{"issue":"8","key":"10.1016\/j.comppsych.2022.152305_bb0025","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.comppsych.2022.152305_bb0030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/YIC.0000000000000237","volume":"33","author":"Fineberg","year":"2018","journal-title":"Int Clin Psychopharmacol"},{"issue":"8","key":"10.1016\/j.comppsych.2022.152305_bb0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/1570159X16666180813155017","article-title":"Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)","volume":"17","author":"Del Casale","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.comppsych.2022.152305_bb0040","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.4103\/0019-5545.196976","article-title":"Clinical practice guidelines for Obsessive-Compulsive Disorder","volume":"59","author":"Janardhan Reddy","year":"2017","journal-title":"Indian J Psychiatry"},{"issue":"4","key":"10.1016\/j.comppsych.2022.152305_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/da.20804","article-title":"Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs","volume":"28","author":"Tolin","year":"2011","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.comppsych.2022.152305_bb0050","article-title":"Obsessive-compulsive disorder-contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19)","volume":"1-9","author":"Jalal","year":"2020","journal-title":"CNS Spectr"},{"key":"10.1016\/j.comppsych.2022.152305_bb0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.janxdis.2016.03.006","article-title":"Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say?","volume":"40","author":"Ong","year":"2016","journal-title":"J Anxiety Disord"},{"key":"10.1016\/j.comppsych.2022.152305_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2021.152223","article-title":"Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: A systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Reid","year":"2021","journal-title":"Compr Psychiatry"},{"issue":"43","key":"10.1016\/j.comppsych.2022.152305_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20430","article-title":"A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children\/adolescents and adults","volume":"20","author":"Skapinakis","year":"2016","journal-title":"Health Technol Assess"},{"issue":"3","key":"10.1016\/j.comppsych.2022.152305_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/16506070510043750","article-title":"Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder","volume":"34","author":"Cottraux","year":"2005","journal-title":"Cogn Behav Ther"},{"issue":"13","key":"10.1016\/j.comppsych.2022.152305_bb0075","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.comppsych.2022.152305_bb0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.comppsych.2022.152305_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaac.2011.09.019","article-title":"Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder","volume":"51","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"16","key":"10.1016\/j.comppsych.2022.152305_bb0090","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","article-title":"Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial","volume":"292","author":"Pediatric OCD Treatment Study (POTS) Team","year":"2004","journal-title":"JAMA."},{"issue":"11","key":"10.1016\/j.comppsych.2022.152305_bb0095","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.2011.1344","article-title":"Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial","volume":"306","author":"Franklin","year":"2011","journal-title":"JAMA."},{"issue":"11","key":"10.1016\/j.comppsych.2022.152305_bb0100","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jamapsychiatry.2013.1932","article-title":"Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial","volume":"70","author":"Simpson","year":"2013","journal-title":"JAMA Psychiat"},{"key":"10.1016\/j.comppsych.2022.152305_bb0105","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.janxdis.2016.08.003","article-title":"Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis","volume":"43","author":"Ost","year":"2016","journal-title":"J Anxiety Disord"},{"issue":"10","key":"10.1016\/j.comppsych.2022.152305_bb0110","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaac.2010.06.013","article-title":"Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I)","volume":"49","author":"Garcia","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.comppsych.2022.152305_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004850-199506000-00001","article-title":"A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder","volume":"10","author":"Greist","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.comppsych.2022.152305_bb0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4088\/JCP.v64n0919","article-title":"Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine","volume":"64","author":"Hollander","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.comppsych.2022.152305_bb0125","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4088\/JCP.v64n0604","article-title":"A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder","volume":"64","author":"Hollander","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.comppsych.2022.152305_bb0130","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1185\/030079907X178838","article-title":"Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study","volume":"23","author":"Stein","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.comppsych.2022.152305_bb0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2020.3650","article-title":"Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: a systematic review and meta-analysis","volume":"78","author":"Guidi","year":"2020","journal-title":"JAMA Psychiat"},{"issue":"8","key":"10.1016\/j.comppsych.2022.152305_bb0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/da.22232","article-title":"Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials","volume":"31","author":"Romanelli","year":"2014","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.comppsych.2022.152305_bb0155","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/wps.20299","article-title":"Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive-compulsive disorder","volume":"15","author":"Mataix-Cols","year":"2016","journal-title":"World Psychiatry"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X22000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X22000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T18:38:12Z","timestamp":1757875092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X22000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"alternative-id":["S0010440X22000116"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2022.152305","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing first line treatments for adults with OCD","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2022.152305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152305"}}